Evidence map›Paper›PMID 31719066›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2020

Disparities in Hepatocellular Carcinoma Incidence in California: An Update.

Meera Sangaramoorthy, Juan Yang, Mindy C DeRouen, Chanda Ho, Ma Somsouk, Michele M Tana, Caroline A Thompson, Joseph Gibbons, Scarlett Lin Gomez, Salma Shariff-Marco

Open access · greenAbstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Article
  3. Ethnic Enclave Residence and Breast, Cervical, and Colorectal Cancer Incidence among Asian American Adults, 2006 to 2017.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Asian American/Pacific Islander and Hispanic Ethnic Enclaves, Neighborhood Socioeconomic Status, and Hepatocellular Carcinoma Incidence in California: An Update.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Article
  12. Comparing Age at Cancer Diagnosis between Hispanics and Non-Hispanic Whites in the United States.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2021
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Meera SangaramoorthyGreater Bay Area Cancer Registry, San Francisco, California.
Juan YangGreater Bay Area Cancer Registry, San Francisco, California.
Mindy C DeRouenGreater Bay Area Cancer Registry, San Francisco, California.
Chanda HoDepartment of Transplantation, California Pacific Medical Center, San Francisco, California.
Ma SomsoukUCSF, Helen Diller Family Comprehensive Cancer Center, San Francisco, California.ORCID 0000-0001-6116-3645
Michele M TanaUCSF, Division of Gastroenterology at Zuckerberg San Francisco General, San Francisco, California.ORCID 0000-0002-3665-2735
Caroline A ThompsonSchool of Public Health, San Diego State University, San Diego, California.
Joseph GibbonsDepartment of Sociology, College of Arts & Letters, San Diego State University, San Diego, California.
Scarlett Lin GomezGreater Bay Area Cancer Registry, San Francisco, California.
Salma Shariff-MarcoGreater Bay Area Cancer Registry, San Francisco, California. sshariff@psg.ucsf.edu.
University of California, San Francisco · USSan Francisco General Hospital · USCalifornia Pacific Medical Center · USSan Diego State University · USUniversity of San Diego · US

Funding

VIRAL MALIGNANCYP30CA023100 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DIANE M SIMEONE · 1985 to 2026
$124.9M
NCCDPHP CDC HHS NU58DP006344NCI NIH HHS HHSN261201800015INCI NIH HHS P30 CA023100
6 · The paper itself

Abstract

backgroundGiven changes in hepatocellular carcinoma (HCC) incidence and the ethnodemographic landscape, we analyzed recent HCC incidence patterns and trends in California.

methodsUsing 47,992 primary, invasive HCC cases diagnosed from 1988 to 2014 from the California Cancer Registry, we calculated age-adjusted incidence rates (IR), annual percent change (APC), and 95% confidence intervals (CI) by sex, race/ethnicity, and nativity among Hispanics and Asian ethnic groups.

resultsCompared with non-Hispanic Whites (NHW), all other racial/ethnic groups had higher HCC incidence. Vietnamese had the highest IRs (males: 47.4, 95% CI, 45.3-49.5; females: 14.1, 95% CI, 13.0-15.3). Foreign-born Chinese, Japanese, Korean, and Vietnamese had higher incidence than U.S.-born. The reverse was observed for Hispanic males, whereas no differences by nativity were seen for Hispanic females. IRs increased most for NHWs. Among Asians, male and female Filipinos and Japanese males experienced rate increases, whereas male and female Koreans and Chinese males experienced rate decreases. U.S.-born male and female Hispanics and Japanese had higher APCs than foreign-born, as did Filipino males, whereas Chinese males had a reverse pattern. Annual increases in HCC incidence slowed down in recent years for U.S.-born Hispanic males and females and stabilized among male NHWs and non-Hispanic Blacks. For some Asian groups, early time periods exhibited increasing/stable APCs, whereas later time periods showed decreasing APCs.

conclusionsWe found significant racial/ethnic and nativity differences in HCC IRs and trends. IMPACT: With changing trends, closer surveillance of HCC incidence by disaggregated race/ethnicity and nativity is warranted among Hispanics and Asians.

Indexed as

Health Status DisparitiesAdultAgedAged, 80 and overAsianCaliforniaCarcinoma, HepatocellularCohort StudiesFemaleHispanic or LatinoHumansIncidenceLiver NeoplasmsMaleMiddle AgedSEER Program

Identifiers

PMID31719066
PMCPMC6986425
OpenAlexW2989128716

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.